Varying effects of tyrosine kinase inhibitors on platelet function—A need for individualized CML treatment to minimize the risk for hemostatic and thrombotic complications?

por Deb, Suryyani, Boknäs, Niklas, Sjöström, Clara, Tharmakulanathan, Anjana, Lotfi, Kourosh, Ramström, Sofia
Publicado 2019